• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,991.22 790.54
( 1.04%)
Global Indices
Nasdaq
51,704.04 -29.67
(-0.06%)
Dow Jones
7,389.07 -104.72
(-1.40%)
Hang Seng
69,343.30 -445.08
(-0.64%)
Nikkei 225
10,454.55 16.70
(0.16%)
Forex
USD-INR
94.53 0.21
(0.22%)
EUR-INR
108.18 0.03
(0.03%)
GBP-INR
125.09 0.39
(0.31%)
JPY-INR
0.58 0.00
(0.06%)

EQUITY - MARKET SCREENER

Smruthi Organics Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
540686
INE172E01011
64.2271775
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
36.33
135.98
EPS(TTM)
Face Value()
Div & Yield %
3.27
10
1.26
 

Dr Lal Pathlabs consolidated net profit declines 15.18% in the March 2026 quarter
Apr 30,2026
Net profit of Dr Lal Pathlabs declined 15.18% to Rs 131.30 crore in the quarter ended March 2026 as against Rs 154.80 crore during the previous quarter ended March 2025. Sales rose 16.61% to Rs 702.70 crore in the quarter ended March 2026 as against Rs 602.60 crore during the previous quarter ended March 2025.

For the full year,net profit rose 3.63% to Rs 504.80 crore in the year ended March 2026 as against Rs 487.10 crore during the previous year ended March 2025. Sales rose 12.25% to Rs 2762.90 crore in the year ended March 2026 as against Rs 2461.40 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales702.70602.60 17 2762.902461.40 12
OPM %26.5828.05 -28.3228.26 -
PBDT204.70189.80 8 861.00766.60 12
PBT160.10153.40 4 699.20624.70 12
NP131.30154.80 -15 504.80487.10 4